Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice

被引:170
作者
Daugherty, A
Cassis, L
机构
[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Pharm, Dept Med, Div Cardiovasc Med, Lexington, KY 40536 USA
来源
THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE UNDERLYING DEFECTS | 1999年 / 892卷
关键词
D O I
10.1111/j.1749-6632.1999.tb07789.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The purpose of this study was to determine the effect of chronic angiotensin IT (AngII) infusion on the severity of the atherogenic process in low density lipoprotein (LDL) receptor -/- mice with established lesions. LDL receptor -/- mice receiving a diet enriched in cholesterol, saturated fat, and cholate, were infused with saline or AngII (500 ng/kg/min) for 28 days. Systolic blood pressure increased in LDL receptor -/- mice following 7 days of AngII infusion, followed by a decline to baseline levels at 28 days, despite continued AngII infusion. Serum cholesterol was not influenced by AngII infusion In LDL receptor -/- mice; however, serum triglyceride concentrations were reduced significantly in LDL receptor -/- mice receiving AngII. The percent of intimal surface area covered by lesion was not increased in LDL receptor -/- mice receiving AngII; however, the content of cholesterol (esterified and unesterified) in lesions of the arch, thoracic, and abdominal aorta was significantly increased in those mice infused with AngII. Of note, in 20% of the LDL receptor -/- mice receiving AngII, large aneurysms were found in the abdominal aorta. Aneurysms appeared as breaks in the media and surrounding tissue of the vessel wail, encompassing amorphous and acellular masses with patches of thrombotic material. These results demonstrate that chronic infusion of AngII promotes the atherogenic processes in LDL receptor -/- mice, manifest as increases in lesion cholesterol content. Effects of AngII to promote atherogenesis mere apparent at doses which did not markedly elevate systolic pressure. Importantly, infusion of AngII: in LDL receptor -/- mice resulted in the development of aortic aneurysms.
引用
收藏
页码:108 / 118
页数:11
相关论文
共 21 条
[1]   EFFECTS OF CAPTOPRIL ON ATHEROSCLEROSIS IN CYNOMOLGUS MONKEYS [J].
ABERG, G ;
FERRER, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S65-S72
[2]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[3]   Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[4]   ACE-INHIBITION WITH PERINDOPRIL AND ATHEROGENESIS-INDUCED STRUCTURAL AND FUNCTIONAL-CHANGES IN MINIPIG ARTERIES [J].
CHARPIOT, P ;
ROLLAND, PH ;
FRIGGI, A ;
PIQUET, P ;
SCALBERT, E ;
BODARD, H ;
BARLATIER, A ;
LATRILLE, V ;
TRANIER, P ;
MERCIER, C ;
LUCCIONI, R ;
CALAF, R ;
GARCON, D .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1125-1138
[5]  
Chen XL, 1998, CIRC RES, V83, P952
[6]   Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease [J].
Cheng, JWM ;
Ngo, MN .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (12) :1499-1506
[7]   ANTIATHEROGENIC EFFECT OF CAPTOPRIL IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
CHOBANIAN, AV ;
HAUDENSCHILD, CC ;
NICKERSON, C ;
DRAGO, R .
HYPERTENSION, 1990, 15 (03) :327-331
[8]   The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice [J].
Daugherty, A ;
Pure, E ;
DelfelButteiger, D ;
Chen, S ;
Leferovich, J ;
Roselaar, SE ;
Rader, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1575-1580
[9]   Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice [J].
Gu, L ;
Okada, Y ;
Clinton, SK ;
Gerard, C ;
Sukhova, GK ;
Libby, P ;
Rollins, BJ .
MOLECULAR CELL, 1998, 2 (02) :275-281
[10]   Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice [J].
Hayek, T ;
Attias, J ;
Smith, J ;
Breslow, JL ;
Keidar, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (04) :540-544